Jubilant Organosys’ two contract manufacturing facilities in North America have successfully completed regulatory cGMP audits. HollisterStier Contract Manufacturing, based in Spokane, WA, completed a successful audit by the Japanese Pharmaceutical and Medical Device Agency (PMDA) for the review of a sterile injectable product for a client.Also, Montreal–based Draxis Pharma, successfully completed an audit by the FDA and Health Canada. The PMDA revealed no significant observations, resulting i...